Differential expression analysis indicated dramatic changes in the expression of KLK 2, 3, 4, 12, 14 and 15. Published literature is consistent with KLK3, 4, 14 and 15 expression changes, but was the opposite for KLK2 in malignant tumors [6, 70]. Here, KLK3 is linked to cancer.